| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.5 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |